Patent Publication Number: US-2023134090-A1

Title: Assembly-type device for treatment of tricuspid regurgitation

Description:
CROSS REFERENCE TO RELATED APPLICATION 
     The present application is a continuation of U.S. application Ser. No. 16/747,431, filed Jan. 20, 2020; which claims priority to Korean Patent Application No. 10-2019-0007774, filed Jan. 21, 2019; all of which are incorporated herein by reference. 
    
    
     BACKGROUND OF THE INVENTION 
     Field of the Invention 
     The present invention relates to an assembly-type device for a treatment of tricuspid regurgitation. More particularly, the present invention relates to an assembly-type device for a treatment of tricuspid regurgitation, wherein the device is provided for treating tricuspid regurgitation (TR), which is a disease where blood from the right ventricle flows back into the right atrium through an empty space (i.e., orifice) formed by incomplete closing of a tricuspid valve (TV), and wherein the device is easily assembled in a patient&#39;s body and the position of a blocking part is easily adjusted. 
     Description of the Related Art 
     The heart is composed of four hollow chambers: the left atrium, the left ventricle, the right atrium, and the right ventricle, and are connected to the aorta, the vena cava, the pulmonary artery, and the pulmonary vein. There are valves between the ventricles and the atria. The valve between the left atrium and the left ventricle is called the mitral valve, and the valve between the right atrium and the right ventricle is called the tricuspid valve. 
     The heart repeats contraction and relaxation to enable blood to circulate. In the systolic phase of the heart, the blood in the heart moves to blood vessels, wherein the blood in the right ventricle flows to the pulmonary artery and the blood in the left ventricle flows to the aorta. 
     However, when a valve is not working properly, blood backflow occurs, thereby causing the blood that must flow into the blood vessels to flow back to the atrium during the cardiac contraction. 
     Tricuspid regurgitation (TR) refers to a symptom of blood backflow from the right ventricle to the right atrium during cardiac contraction through an orifice, wherein, since the tricuspid valve (TV) between the right atrium and the right ventricle is stretched or torn, or since the chordae tendineas holding the tricuspid valve is broken, the tricuspid valve closes incompletely when the tricuspid valve needs to be closed, resulting in the orifice. This is also called tricuspid valve insufficiency. 
     U.S. Pat. Nos. 8,486,136 B2, 7,854,762 B2, and 9,474,605 B2 disclose devices for treating tricuspid regurgitation, and the devices for treating tricuspid regurgitation are inserted into the superior vein cava, the tricuspid valve, and the right ventricle in sequence, and block the orifice of the tricuspid valve, thereby treating the tricuspid regurgitation. In the devices for the treatment of tricuspid regurgitation, an anchor installed at one end of each device is fixed to the ventricle, and the other end thereof is fixed to the outside of the heart by passing through the superior vein cava. Accordingly, the blocking part of the related patents is placed in an unstable state of passing through the centerline of the orifice of the tricuspid valve with a longitudinal orientation and floating within the heart. 
     The fixing device of the conventional devices for treatment of tricuspid regurgitation is fixed to the ventricle and a position outside the heart. Since the heart is positioned above the diaphragm and the heart moves up and down according to the vertical movement of the diaphragm during breathing, the conventional devices for the treatment of tricuspid regurgitation move up and down according to the movement of the diaphragm during the breathing. When this movement is repeated, there occurs a problem in that the blocking part is positioned off the centerline of the orifice of the tricuspid valve. When the blocking part deviates from the centerline of the orifice of the tricuspid valve, the function of the tricuspid valve is adversely affected. 
     Moreover, in Korean Patent No. 10-1805679 invented by the present inventor, a device for the treatment of the tricuspid regurgitation, the device having a blocking part which is obliquely passed through the tricuspid valve by connecting the coronary sinus and the ventricular septum, is filed and is registered. The blocking part is stably positioned inside the heart, but requires a relatively difficult treatment with passing through the ventricular septum. 
     Documents of Related Art 
     
         
         (Patent Document 1) U.S. Pat. No. 8,486,136 B2 (Jul. 16, 2013) 
         (Patent Document 2) U.S. Pat. No. 7,854,762 B2 (Dec. 21, 2010) 
         (Patent Document 3) U.S. Pat. No. 9,474,605 B2 (Oct. 25, 2016) 
         (Patent Document 4) KR 101805679 (Nov. 30, 2017) 
       
    
     SUMMARY OF THE INVENTION 
     The present invention is to provide an assembly-type device for a treatment of tricuspid regurgitation that may simply treat tricuspid regurgitation by passing through the inferior vena cava, the tricuspid valve, and the pulmonary artery in sequence in order to solve the problem of the related art. 
     In addition, the present invention is to provide an assembly-type device for a treatment of tricuspid regurgitation that may be obliquely passed through the orifice of the tricuspid valve to stably block the orifice of the tricuspid valve. 
     In addition, the present invention is to provide an assembly-type device for a treatment of tricuspid regurgitation that is configured to easily maintain the centerline orientation of the orifice of the tricuspid valve without being affected by the movement of the diaphragm during breathing. 
     In addition, the present invention is to provide an assembly-type device for a treatment of tricuspid regurgitation that is configured to easily adjust the device position to precisely block the orifice of the tricuspid valve during the treatment. 
     The objectives of the present invention are not limited to the above-mentioned objectives, and other objectives that are not mentioned will be clearly understood by those skilled in the art from the following description. 
     In order to achieve the objectives, there is provided an assembly-type device for a treatment of tricuspid regurgitation according to the present invention, the device including: a fixing member for pulmonary artery, the fixing member being installed in the pulmonary artery; a connecting tube provided with a connecting tube lumen formed therein to be movable along a connecting wire; an assembly part provided with a first assembly coupled to a lower end of the fixing member for the pulmonary artery and a second assembly coupled to an upper end of the connecting tube, thus allowing the fixing member for the pulmonary artery and the connecting tube to be assembled together; a fixing member for inferior vena cava, the fixing member being coupled to a lower end of the connecting tube and installed in the inferior vena cava; and a blocking part coupled to one side of the connecting tube and obliquely passing through a tricuspid valve to block an orifice of the tricuspid valve. 
     A screw thread may be formed on an inner circumferential surface of the first assembly, and a screw thread corresponding to the screw thread of the first assembly may be formed on an outer circumferential surface of the second assembly so that the first assembly and the second assembly may be engaged with each other. 
     According to another exemplary embodiment, the first assembly may be spherical in shape, and the second assembly may be an elastic tong, having elasticity, in a shape of the tong surrounding the first assembly, and wherein the second assembly may be unfolded along an outer surface of the first assembly when the second assembly is pushed toward the first assembly, and then, may be returned to an original state by the elasticity. 
     According to yet another exemplary embodiment, the first assembly may be provided with a fastening groove formed on a side surface thereof, and the second assembly may be provided with a fastening protrusion formed on a side surface thereof, and wherein the fastening protrusion may be inserted into the fastening groove when the second assembly is pushed toward the first assembly so that the first assembly and the second assembly may be assembled together. 
     In addition, according to a preferred exemplary embodiment of the present invention, the assembly-type device for a treatment of tricuspid regurgitation may further include: a connecting wire assembly part including: a first connecting wire assembly coupled to one side of the first assembly and provided with a screw thread formed on an inner circumferential surface thereof; and a second connecting wire assembly coupled to an upper end of the connecting wire and provided with a screw thread corresponding to the screw thread formed in the first connecting wire assembly on an outer circumference thereof, wherein the connecting wire assembly part may be assembled in a screw-type engagement, and may be disassembled by rotating the connecting wire. 
     According to the preferred exemplary embodiment of the present invention, the fixing member for the pulmonary artery and the fixing member for the inferior vena cava may have a radial structure. 
     According to another preferred exemplary embodiment of the present invention, the fixing member for the pulmonary artery and the fixing member of the inferior vena cava may be configured as a ribbon shape. 
     In addition, according to the present invention, the assembly-type device for a treatment of tricuspid regurgitation may further include: a sheath tube having a tube shape and provided with a lumen formed therein into which the assembly-type device for the treatment of the tricuspid regurgitation may be inserted, wherein, when inserting into a patient&#39;s body, the assembly-type device for the treatment of the tricuspid regurgitation may be inserted into the sheath tube and moves in a folded state, and when removing the sheath tube upon reaching a target position, the assembly-type device for the treatment of the tricuspid regurgitation may be unfolded. 
     According to the preferred exemplary embodiment of the present invention, the blocking part may include: a supporting wire having both ends thereof coupled to the connecting tube; and a blocking membrane having one side thereof fixed to the connecting tube and supported by the supporting wire. 
     According to the another preferred exemplary embodiment of the present invention, the blocking part may be a blocking balloon in a form of a balloon that may be expanded or contracted, and wherein the blocking part may further include a balloon tube having an upper end thereof connected to and communicated with the blocking balloon, and a balloon-adjusting hub connected to another end of the balloon tube, installed outside the patient&#39;s body, and expanding or contracting the blocking balloon. 
     According to yet another preferred exemplary embodiment of the present invention, the blocking part may include: a ring-shaped wire installed for the connecting tube to be passed through and provided with a central axis foamed obliquely to the connecting tube, and a blocking membrane connecting the connecting tube and the ring-shaped wire to each other. 
     The assembly-type device for the treatment of tricuspid regurgitation according to the present invention may be passed through the inferior vena cava, the tricuspid valve, and the pulmonary artery in sequence, so as to enable the blocking part to be simply positioned in the orifice of the tricuspid valve. 
     In addition, by using the assembly-type device for the treatment of tricuspid regurgitation according to the present invention, the tricuspid regurgitation may be efficiently treated with a non-invasive method and a short treatment time. 
     In addition, the blocking part may obliquely pass through the centerline of the orifice of the tricuspid valve to stably block the orifice of the tricuspid valve. 
     In addition, fixing members are fixed to the pulmonary artery and the inferior vena cava so that the position of the blocking part is not affected by the movement of the diaphragm during breathing. 
     In addition, the assembly-type device for the treatment of tricuspid regurgitation according to the present invention has little interaction with the chordae tendineas or the papillary muscle, which are the substructure of the tricuspid valve, thereby having no possibility of problems caused by the interaction. 
     In addition, since the present invention provides a device being assembled inside the patient&#39;s body, the blocking part may be precisely positioned in the orifice of the tricuspid valve, and thus a customized treatment may be possible according to the patient. 
    
    
     
       BRIEF DESCRIPTION OF THE DRAWINGS 
         FIG.  1    is a perspective view of an assembly-type device for a treatment of tricuspid regurgitation according to a preferred exemplary embodiment of the present invention. 
         FIG.  2    is a perspective cross-sectional view of an assembly part according to the preferred exemplary embodiment of the present invention. 
         FIG.  3    is a cross-sectional view of a connecting wire assembly part according to the preferred exemplary embodiment of the present invention. 
         FIG.  4    is a view showing an assembly part according to another exemplary embodiment of the present invention, in which a second assembly part is coupled to a first assembly part. 
         FIG.  5    is a perspective view of the assembly part according to yet another preferred exemplary embodiment of the present invention. 
         FIG.  6    is a perspective view showing the assembly-type device for the treatment of tricuspid regurgitation installed with another fixing member for the pulmonary artery and another fixing member for the inferior vena cava according to the present invention. 
         FIGS.  7 A to  7 C  are perspective views showing an exemplary embodiment of various blocking parts according to the present invention. 
         FIGS.  8  to  12    show in order a method of treating by using the assembly-type device for the treatment of tricuspid regurgitation according to the preferred exemplary embodiment of the present invention. 
     
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
     Benefits and features of the present invention and methods of accomplishing the same may be understood more readily by reference to the following detailed description of exemplary embodiments and the accompanying drawings. However, the present disclosure may be embodied in many different forms, and should not be construed as being limited to the exemplary embodiments set forth herein. Rather, these exemplary embodiments are provided so that this disclosure will be thorough and complete and will fully convey the concept of the invention to those skilled in the art, and the present disclosure will only be defined by the appended claims. 
     Hereinafter, the preferred exemplary embodiments of the present invention will be described in detail with reference to the accompanying drawings. 
     An assembly-type device for a treatment of tricuspid regurgitation according to the present invention is a device in which components are assembled in a patient&#39;s body, and the position of a blocking part is easily adjusted according to the patient, thereby treating tricuspid regurgitation by blocking an orifice formed by incomplete closing of the tricuspid valve. 
       FIG.  1    is a perspective view of the assembly-type device for the treatment of tricuspid regurgitation according to the preferred exemplary embodiment of the present invention. 
     Referring to  FIG.  1   , the assembly-type device for the treatment of tricuspid regurgitation according to the preferred exemplary embodiment of the present invention includes a blocking part  10 , a connecting tube  20 , a fixing member for the pulmonary artery  30 , a fixing member for the inferior vena cava  60 , and an assembly part  70 . 
     First, referring to the fixing member for the pulmonary artery  30  according to the preferred exemplary embodiment of the present invention, the fixing member for the pulmonary artery  30  is installed in the pulmonary artery, is provided with a lower end thereof coupled to the assembly part  70 , and has a radial structure. 
     The fixing member for the pulmonary artery  30  may be made of a metal wire (i.e., stainless steel, nylon coating on metal, etc.), and is composed of a shape memory alloy, an elastic body, or a self-expandable stent. 
     The self-expandable stent refers to a stent capable of self-expansion with a frame made of Nitinol alloy. 
     The lower end of the fixing member for the pulmonary artery  30  is coupled to the assembly part  70 , and the upper end thereof unfolds radially upward and is inserted in a folded state when inserted into a sheath tube  40  for insertion into the patients&#39; body. When reaching a target position of the pulmonary artery and protruding out of the sheath tube  40 , the fixing member for the pulmonary artery  30  is unfolded and returned to its original state, and is installed in the pulmonary artery. 
     The sheath tube  40  has the same shape as a general purpose catheter and is provided with a lumen into which the assembly-type device for the treatment of tricuspid regurgitation is inserted. 
     The sheath tube  40  is formed long enough to be operated at a position of the patient&#39;s thigh by an operator. The material of the sheath tube  40  may be synthetic resin material such as rubber, soft plastic, etc., and is made of a material having high flexibility and excellent resilience to be movable according the heartbeat. 
     The assembly part  70  coupled to the lower end of the fixing member for the pulmonary artery  30  may have a polygonal column shape such as a triangular column shape, a square column shape, or the like, but preferably has a cylindrical shape. 
     Detailed description of the assembly part  70  will be described with reference to  FIG.  2   . 
       FIG.  2    is a perspective cross-sectional view of the assembly part according to the preferred exemplary embodiment of the present invention. Referring to  FIG.  2   , the assembly part  70  includes a first assembly  72  and a second assembly  74 . 
     The first assembly  72  has a shape (Π) recessed upwardly from the bottom surface thereof, the top surface thereof is closed and the bottom surface thereof is open. A screw thread is formed on the inner circumferential surface of the first assembly  72 . 
     In addition, the connecting wire assembly part  90  is coupled to the inner upper surface of the recessed space of the first assembly  72 . One end of the connecting wire  80  is coupled to the bottom surface of the connecting wire assembly part  90 , and a detailed description of the connecting wire assembly part  90  will be described in more detail with reference to  FIG.  3   . 
     The second assembly  74  is coupled to the upper end of the connecting tube  20 , wherein, on the outer circumferential surface of the second assembly, a screw thread corresponding to the screw thread formed on the first assembly  72  is formed, and the inside thereof has a cavity so that the connecting wire assembly part  90  and the connecting wire  80  are inserted. 
     The diameter of the second assembly  74  is preferably smaller than the diameter of the first assembly  72 . Thus, the second assembly  74  is inserted into the recessed space of the first assembly  72  and engaged with each other. First, the diameter of the first assembly  72  inserted into the patient&#39;s body is to be greater than the diameter of the second assembly  74 , so that the treatment is more convenient. 
     The first assembly  72  and the second assembly  74  is made of a rigid metal (i.e., stainless steel, nylon coating on the metal) or plastics to facilitate to be engaged with each other. 
     In the case when the first assembly  72  and the second assembly  74  are engaged with each other more than half, the assembly part  70  has a binding power with such a degree that disassembly thereof by the movement of the heart is prevented. 
     Therefore, the second assembly  74  is further rotatable after being coupled with the first assembly  72 . At this time, it is desirable that the direction of rotation of the second assembly  74  is in the direction that may be better coupled to the assembly part  70 . As the operator moves the connecting tube  20  to the left and right, the second assembly  74  is rotated and the blocking part  10  coupled to the connecting tube  20  is moved to the left and right, so that the position of the blocking part  10  is adjusted. 
     Referring back to  FIG.  1   , the connecting tube  20  has a connecting tube lumen  22  formed therein to move along the connecting wire  80 . The diameter of the connecting tube  20  is preferably formed the same as the second assembly  74 , but is not limited thereto. 
     The connecting tube  20  may be synthetic resin material such as rubber, soft plastic, etc., and is made of a material having high flexibility and excellent resilience to be movable according to the heartbeat. 
     The second assembly  74  is coupled to the upper end of the connecting tube  20 , and the fixing member for the inferior vena cava  60  is coupled to the lower end thereof. 
     The fixing member for the inferior vena cava  60  is to be installed in the inferior vena cava, wherein the lower end thereof is coupled along the outer circumferential surface of the connecting tube  20  at the lower end of the connecting tube  20 , and the upper end thereof is formed in a radial structure which is unfolded upward of the connecting tube  20 . 
     The fixing member for the inferior vena cava  60  may be made of a metal wire (i.e., stainless steel, nylon coating on metal, etc.), and is composed of a shape memory alloy, an elastic body, or a self-expandable stent. 
     The self-expandable stent refers to a stent capable of self-expansion with a frame made of Nitinol alloy. 
     The fixing member for the inferior vena cava  60  is inserted in a deformed shape when inserted into the sheath tube  40  for insertion into the patient&#39;s body, is returned to its original state when the sheath tube  40  is removed, and is installed to the inferior vena cava. 
     The blocking part  10  blocks the orifice by obliquely passing through the orifice of the tricuspid valve, and is coupled to one side of the connecting tube  20 . 
     The blocking part  10  includes a supporting wire  14  having both ends thereof coupled to the connecting tube  20 , and includes a blocking membrane  12  having one side thereof fixed to the connecting tube  20  and supported by the supporting wire  14 . 
     When inserted into the sheath tube  40 , the blocking part  10  is unfolded and inserted in a foam surrounding the outer circumferential surface of the connecting tube  20 . Various exemplary embodiments of the blocking part  10  will be described in detail with reference to  FIGS.  7 A to  7 C  described below. 
       FIG.  3    is a cross-sectional view of the connecting wire assembly part according to the preferred exemplary embodiment of the present invention. Referring to  FIG.  3   , the connecting wire assembly part  90  includes a first connecting wire assembly  92  and a second connecting wire assembly  94 . The connecting wire assembly part  90  is preferably formed in a cylindrical shape. 
     The first connecting wire assembly  92  is preferably coupled to the inner upper surface of the recessed part of the first assembly part  72  as described above, but is not limited thereto. 
     The first connecting wire assembly  92 , having a shape (Π) recessed upward from the lower surface thereof, has the same shape as the first assembly  72 . A screw thread is formed on the inner circumferential surface of the recessed part. 
     The second connecting wire assembly  94  is provided with a screw thread formed at a position on the outer circumferential surface thereof and corresponding to a screw thread of the first connecting wire assembly  92 . The first connecting wire assembly  92  and the second connecting wire assembly  94  are engaged with each other. 
     The connecting wire  80  has an upper end thereof bonded to the lower surface of the second connecting wire assembly  94 , and a lower end thereof formed long enough to be positioned outside of the patient&#39;s body through the thigh. The connecting wire  80  is composed of the same material as a guidewire  50 , and is made of synthetic resin such as nylon, or metal wire (i.e., stainless steel, nylon coating on metal, etc.), and the like. 
     The connecting wire  80  is rotated at a position outside the patient&#39;s body to enable the connecting wire assembly part  90  to be coupled or disassembled. 
       FIG.  4    is a view showing a first assembly part and a second assembly part according to another exemplary embodiment of the present invention, wherein the second assembly part is coupled to the first assembly part. 
     Referring to the assembly part  70  according to the another preferred exemplary embodiment of the present invention, the first assembly  72  is preferably formed in a spherical shape, and is composed of a rigid material such as metal or rigid plastic. 
     The second assembly  74  has elasticity with a shape of a rounded tong to surround the first assembly  72 . When the operator pushes toward the first assembly  72 , the second assembly  74  unfolds along a rounded outer surface of the first assembly  72  from the lower end thereof. Then, when reaching the upper end of the first assembly  72 , the second assembly  74  is returned to its original state by elasticity. The final coupling state is that the second assembly  74  is coupled to surround the entire first assembly  72 . 
     The coupling of the first assembly  72  and the second assembly  74  according to the another preferred exemplary embodiment of the present invention is not affected by the movement of the heart, but is rotatable to the left and right by the force exerted by the operator outside the patient&#39;s body. As the operator moves the connecting tube  20  to the left and right, the second assembly  74  is rotated to the left and right and the blocking part  10  coupled to the connecting tube  20  moves along the connecting tube  20 , thereby the position of the blocking part  10  is capable of being adjusted. 
     In this case, the first connecting wire assembly  92  is coupled to the lower surface of the first assembly  72 . The shapes of the connecting wire assembly part  90  and the connecting wire  80  are the same as described in detail with reference to  FIG.  3   . 
       FIG.  5    is a perspective view of the assembly part according to yet another preferred exemplary embodiment of the present invention. 
     Referring to  FIG.  5   , the first assembly  72 , according to the yet another preferred exemplary embodiment of the present invention, has a cylindrical shape provided with a fastening groove  72   a  on the side surface thereof, wherein the fastening groove  72   a  is provided longer in width than in height. Preferably, the first assembly  72  is recessed upward from the lower surface thereof, and the second assembly  74  is inserted into and coupled to the recessed part of the first assembly  72 . 
     The second assembly  74 , having a cylindrical shape, is preferably provided to have a diameter smaller than the diameter of the first assembly  72 , and includes a fastening protrusion  74   a  provided at a position on one side of an outer circumferential surface thereof. The fastening protrusion  74   a  is elastic and has a lower part thereof provided thicker than the upper part thereof. 
     When the second assembly  74  is pushed upward to insert the second assembly  74  into the first assembly  72 , the fastening protrusion  74   a  is pressed. Then, when the fastening protrusion  74   a  reaches the fastening groove  72   a , the fastening protrusion  74   a  is returned to the unpressed state again. Thus, the assembly part  70  is assembled by engaging the fastening protrusion  74   a  with the fastening groove  72   a.    
     The fastening protrusion  74   a  is not affected by the movement of the heart, and the coupling of the assembly part  70  is not disassembled. The fastening protrusion  74   a  is movable in the width direction within the fastening groove  72   a  by a force exerted by the operator outside the patient&#39;s body. As the operator moves the connecting tube  20  to the left and right, the second assembly  74  may be rotated to the left and right to adjust the position of the blocking part  10 . 
     In addition, the second assembly  74  has a cavity therein, so that the connecting wire assembly part  90  or the connecting wire  80  is inserted. The first connecting wire assembly  92  is coupled to the upper surface of the recessed part of the first assembly  72 , and the shape thereof is the same as described above in  FIG.  3   . 
       FIG.  6    is a perspective view showing the assembly-type device for the treatment of tricuspid regurgitation installed with another fixing member for the pulmonary artery and another fixing member for the inferior vena cava according to the present invention. 
     Referring to  FIG.  6   , each of the another fixing member for the pulmonary artery  30  and fixing member for the inferior vena cava  60  is respectively provided in a ribbon shape having a convex center, is made of a metal wire (i.e., stainless steel, nylon coating on metal, etc.), and is composed of a shape memory alloy, an elastic body, or a self-expandable stent. 
     The self-expandable stent refers to a stent capable of self-expansion with a frame made of Nitinol alloy. 
     When inserted into the sheath tube  40 , the fixing member for the pulmonary artery  30  and the fixing member for the inferior vena cava  60  are deformed, and when the sheath tube  40  is removed, each of the central parts thereof is returned to a ribbon shape with a convex center, and are respectively installed in the pulmonary artery and inferior vena cava. 
       FIGS.  7 A to  7 C  are perspective views showing the exemplary embodiment of various blocking parts according to the present invention. 
     The blocking part  10  of  FIG.  7 A  is composed of a blocking membrane  12  and a supporting wire  14  as described above with reference to  FIG.  1   , thereby blocking the orifice formed by incomplete closing of the tricuspid valve. Both ends of the supporting wire  14  are coupled to the connecting tube  20 , and one side of the blocking membrane  12  is fixed to the connecting tube  20  and supported by the supporting wire  14 . 
     The material of the supporting wire  14  may be synthetic resin such as nylon or metal wire (i.e., stainless steel, nylon coating on metal), and the like. The blocking membrane  12  has softness but is not easily torn, uses a material suitable for human body, and preferably is made of medical polyurethane, polyolefin, silicone, e-PTFE, PTFE, and the like. The blocking membrane  12  is made of one, two or more layers thereof. 
     When inserted into the sheath tube  40 , the blocking part  10  of  FIG.  7 A  is inserted in a foil being surrounded on the outer circumferential surface of the connecting tube  20 . Also, when removed from the sheath tube  40 , the blocking part  10  is returned to its unfolded form and blocks the orifice of the tricuspid valve. 
     The blocking part  10  of  FIG.  7 B  includes a blocking balloon  16 , a balloon tube  17 , and a balloon-adjusting hub  18 . The blocking balloon  16  is installed at one side of the connecting tube  20  to block the orifice formed due to the incomplete closing of the tricuspid valve. One end of the balloon tube  17  is coupled to and communicates with the blocking balloon  16  while maintaining airtightness, and the other end of the balloon tube  17  is coupled to the balloon-adjusting hub  18  positioned outside the patient&#39;s body. 
     When the operator adjusts the balloon-adjusting hub  18  outside the patient&#39;s body and supplies air to the blocking balloon  16  through the balloon tube  17 , the blocking balloon  16  is inflated. Also, when the air is removed, the blocking balloon  16  is reduced in size. The balloon-adjusting hub  18  injects air, oxygen, and form, and the supply amount is adjusted by the operator outside the patient&#39;s body, and thus the size of the blocking balloon  16  is changed in size. The size of the blocking balloon  16  may be adjusted according to the size of the orifice formed due to the incomplete closing of the tricuspid valve when the heart contracts. 
     The blocking part  10  of  FIG.  7 C  includes a blocking membrane  12  and a ring-shaped wire  19 . The ring-shaped wire  19  is installed for the connecting tube  20  to pass through, the central axis thereof is formed obliquely with respect to the connecting tube  20 , and the blocking membrane  12  connects the connecting tube  20  and the ring-shaped wire  19  to each other. Since the ring-shaped wire  19  has a central axis formed obliquely to the connecting tube  20 , the ring-shaped wire  19  is positioned in parallel with the tricuspid valve inclined at a certain angle, thereby effectively blocking the orifice of the tricuspid valve. The ring-shaped wire  19  may be made of synthetic resin such as nylon or metal (i.e., stainless steel, nylon coating on metal), and the like. In addition, the material of the blocking membrane  12  is the same as the material of the blocking membrane of  FIG.  7 A . 
       FIGS.  8  to  12    show in order a method of treating by using the assembly-type device for the treatment of tricuspid regurgitation according to the preferred exemplary embodiment of the present invention. 
     Referring to  FIG.  8   , the guidewire  50  is first inserted into the inferior vena cava, the tricuspid valve, and the pulmonary artery in sequence to provide a path for the assembly-type device for the treatment of tricuspid regurgitation, so as to easily move into the patient&#39;s body. The material of the guidewire  50  may be synthetic resin such as nylon or metal wire (i.e., stainless steel, nylon coating on metal, etc.), and the like. Also, it is desirable that the guidewire has a diameter of about 0.014″. 
     Thereafter, the sheath tube  40  is inserted into the patient&#39;s body along the guidewire  50 . 
     As shown in  FIG.  9   , after the guidewire  50  is removed, the fixing member for the pulmonary artery  30 , the first assembly  72  coupled to the fixing member for the pulmonary artery  30 , the connecting wire assembly part  90  coupled to the first assembly  72 , and the connecting wire  80  coupled to the connecting wire assembly part  90  are inserted into the sheath tube  40 . 
     In this case, the lower end of the connecting wire  80  is positioned outside the patient&#39;s body and may be adjusted by the operator. By pushing the connecting wire  80  upwards, the fixing member for the pulmonary artery  30  is unfolded and installed in the pulmonary artery. 
     Next, as shown in  FIG.  10   , the connecting tube  20 , the blocking part  10  coupled to one side of the connecting tube  20 , fixing member for the inferior vena cava  60  coupled to the lower end of the connecting tube  20 , and the second assembly  74  coupled to the upper end of the connecting tube  20  are inserted into the sheath tube  40 . 
     At this time, the connecting wire  80  is inserted into the connecting tube  20  and moves into the patient&#39;s body along the connecting wire  80 . 
     The blocking part  10  and the fixing member for the inferior vena cava  60  are inserted into the sheath tube  40  in a deformed state by being inserted into a general purpose catheter (not shown), and the general purpose catheter (not shown) is provided long to be operable at the thigh. 
     At this time, the sheath tube  40  is removed, and the blocking part  10  and the fixing member for the inferior vena cava  60 , which are inserted into the general purpose catheter (not shown), may be inserted along the connecting wire  80 . 
     By rotating or pushing the general purpose catheter (not shown) to assemble the second assembly  74  with the first assembly  72 , the assembly-type device for the treatment of tricuspid regurgitation according to the present invention is made as one device. The general purpose catheter (not shown) is removed outside the patient&#39;s body in this stage. 
     Thereafter, as shown in  FIG.  11   , the sheath tube  40  is pulled downward so that the blocking part  10  protrudes to the outside from the sheath tube  40 . Then, the sheath tube  40  is adjusted to the left and right to rotate at the thigh so that the connecting tube  20  inserted into the sheath tube  40  is rotated. As the connecting tube  20  is rotated, the second assembly  74  coupled to the upper end of the connecting tube  20  is rotated, which does not affect the coupling force of the assembly part  70 . In addition, as the connecting tube  20  is rotated, the blocking part  10  coupled to the connecting tube  20  is rotated so that the position of the blocking part  10  is adjusted. 
     The position of the blocking part  10  is adjusted to be positioned in the orifice of tricuspid valve, which varies depending on different patients, and then, by pulling the sheath tube  40  downward, the fixing member for the inferior vena cava  60  is unfolded and fixed to the inferior vena cava. 
     Finally, the sheath tube  40  is completely removed from the patient&#39;s body as shown in  FIG.  12   , and the screw connection of the connecting wire assembly part  90  is disassembled. Thereafter, the connecting wire  80  is removed out of the patient&#39;s body, and thus the assembly-type device for the treatment of tricuspid regurgitation according to the present invention is installed in the patient&#39;s body. 
     As described above, the assembly-type device for the treatment of tricuspid regurgitation according to the present invention is assembled in the patient&#39;s body, and the position of the blocking part is capable of being adjusted to be positioned precisely in the orifice of the tricuspid valve, whereby it is possible to perform customized treatment according to the patient. 
     Although the exemplary embodiments of the present invention have been described above with reference to the accompanying drawings, it will be understood that those skilled in the art to which the present invention pertains may implement the present invention in other specific forms without departing from the technical spirit or essential features thereof. Therefore, the exemplary embodiments described above are to be understood in all respects as illustrative and not restrictive.